期刊文献+

无抽搐电休克治疗仪联合药物治疗精神分裂症的疗效观察 被引量:2

Observation on the Curative Effect of Non-convulsive Electric Shock Therapy Instrument Combined with Drugs in Treating Schizophrenia
下载PDF
导出
摘要 目的:探讨无抽搐电休克治疗仪联合药物治疗精神分裂症的疗效。方法:选择118例精神分裂症患者,随机分为两组各59例,对照组单用药物治疗,研究组在其基础上使用无抽搐电休克治疗仪治疗。治疗前后分别采取阳性症状与阴性症状量表(PANSS)和可重复的成套神经心理状态测验(RBANS)对患者进行评估。结果:治疗后,研究组阳性症状为(16.42±3.15)分,阴性症状为(24.47±4.52)分,一般精神病理为(23.20±3.14)分,明显低于对照组(19.18±3.52)分,(28.10±4.50)分,(28.11±3.63)分,比较具有明显差异(P<0.05)。研究组RBANS评分为(127.40±23.47)分,对照组为(127.18±25.63)分,比较无明显差异(P>0.05)。结论:联用无抽搐电休克治疗仪能够改善精神分裂症的症状,并对认知功能无明显影响。 Objective:To explore the curative effect of non-convulsive electric shock therapy device combined with drugs in the treatment of schizophrenia.Methods:118 patients with schizophrenia were selected and randomly divided into two groups with 59 cases in each group.The control group was treated with drugs alone,and the study group was treated with a non-convulsive electric shock therapy device on the basis of this.The Positive and Negative Symptom Scale(PANSS)and the Repeatable Neuropsychological State Test(RBANS)were used to evaluate the patients before and after treatment.Results:After treatment,the positive symptoms of the study group were(16.42±3.15)points,the negative symptoms were(24.47±4.52)points,and the general psychopathology was(23.20±3.14)points,which was significantly lower than the control group(19.18±3.52)points,(28.10±4.50)points,(28.11±3.63)points,there is a significant difference(P<0.05).The RBANS score of the study group was(127.40±23.47)points,and the control group was(127.18±25.63)points,and there was no significant difference(P>0.05).Conclusion:The combined use of non-convulsive electric shock therapy device can improve the symptoms of schizophrenia,and has no obvious impact on cognitive function.
作者 赵鹏 ZHAO Peng(Dandong Third Hospital,Liaoning Dandong 118000)
机构地区 丹东市第三医院
出处 《中国医疗器械信息》 2020年第16期158-159,共2页 China Medical Device Information
关键词 无抽搐电休克治疗仪 精神分裂症 临床疗效 non-convulsive electric shock therapy device schizophrenia clinical efficacy
  • 相关文献

参考文献7

二级参考文献57

  • 1陈日访.现代电休克治疗精神分裂症的疗效比较结果[J].四川精神卫生,2004,17(3):158-159. 被引量:19
  • 2潘能荣,杨小男,张承安,梅其一.电休克治疗对抑郁症的疗效研究[J].临床精神医学杂志,2005,15(2):75-77. 被引量:77
  • 3徐婉姣,金怡,黄悦勤,刘肇瑞,何华,陈进.脑电引导重复经颅磁刺激治疗精神分裂症的随机双盲对照实验[J].中国临床康复,2006,10(46):22-24. 被引量:23
  • 4Stip E. The effect of Risperidone on congition in patients with schizophrenia [J]. Can J Psychiatry, 1996, 41(2): 35-40.
  • 5Mehzer HY, Bobo WV, Nuamah IF, et al. Efficacy and tolerabil- ity of oral paliperidone extended-release tablets in treatment of acute schizophrenia: pooled data from three 6-week, place- bo-controlled studies [J]. J Clin Psychiatry, 2008, 69(5): 817-829.
  • 6中华医学会精神科分会.中国精神障碍分类与诊断标准(CCMD3)[M]3版.济南:山东科学技术出版社,2001.75-81.
  • 7Kao YC,Liuy P,Lieny J,et al.The influence of sex on cognitive insight and neurocognitive functioning in schizophrenia[J].Prog Neuropsychopharmacol Biol Psychiatry,2013,44(3):193-200.
  • 8Martinotti G,Ricci V,Di Nicola M,et al.Brain-derived neurotrophic factor and electroconvulsive therapy in a schizophrenic patient with treatment-resistant paranoid-hallucinatory symptoms[J].J Ect,2011,27(1):e44-e46.
  • 9Kahn RS, Keefe RS. Schizophrenia is a cognitive illness : time for a change in tbcus[ Jl. JAMA Psychiatry, 2013,70(10) : 1107- 1112.
  • 10Bowie CR, Reichenberg A, Patterson TL, et al. Determinants of zal-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms [J]. Am J Psychiatry, 2006,163(3) :418-425.

共引文献291

同被引文献14

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部